Background
Rationale
Aim and research question
Methods
-
Difference and/or equivalence of SI in survivors and non-survivors
-
Difference and/or equivalence of %ΔSI in survivors and non-survivors
Patient cohort
Cohort 1 | Survivors | Non-survivors |
p Value | |
---|---|---|---|---|
Number of subjects | 145 | 119 (82%) | 26 (18%) | |
Age, years | 67 [57–75] | 66 [57–74] | 73 [59–78] | 0.15 |
Sex, M/F | 91/54 | 75/44 | 16/10 | 1.00 |
APACHE II score | 20 [17–26] | 19 [16–25] | 22 [19–31] | <0.01 |
First-day SOFA score | 6 [4–8] | 6 [4–8] | 8 [6–8] | 0.02 |
Cardiac | 3 [1–4] | 3 [1–4] | 4 [1–4] | |
Pulmonary | 3 [2–4] | 3 [2–3] | 3 [2–4] | |
Hepatic | 0 [0–0] | 0 [0–0] | 0 [0–1] | |
Renal | 0 [0–0] | 0 [0–0] | 0 [0–0] | |
Coagulation | 0 [0–1] | 0 [0–1] | 0 [0–0] | |
ICU length of stay, h | 113 [65–212] | 127 [65–256] | 108 [65–154] | 0.49 |
SPRINT duration, h | 83 [44–159] | 81 [42–168] | 101.5 [55–126] | 0.93 |
Diabetes mellitus type 1/type 2, % of total | 9/24 (33) | 8/21 (29) | 1/3 (4) | 1.00 |
Cohort BG, mmol/L | 5.7 [4.9–6.7] | 5.8 [5.0–6.8] | 5.5 [4.8–6.4] | <0.01a
|
Per-patient BG, mmol/L | 5.7 [5.2–6.2] | 5.8 [5.2–6.2] | 5.3 [5.1–5.9] | 0.03 |
Per-patient % BG 4.4–8 mmol/L (% all BG) | 82.8 [71.9–89.5] (79.3) | 82.1 [72.2–89.3] (79.1) | 83.3 [70.4–94.4] (80.0) | 0.71 |
Per-patient % BG <4 mmol/L (% all BG) | 1.4 [0.0–5.6] (3.4) | 1.4 [0.0–4.2] (3.0) | 1.9 [0.0–8.5] (5.0) | 0.19 |
Patients with BG <2.2 mmol/L, n
| 0 | 0 | 0 | |
BG measurements per day | 15.8 [14.5–17.7] | 15.8 [14.4–18.0] | 15.7 [14.8–16.2] | 0.80 |
Per-patient median insulin, U/h | 3 [2–3] | 3 [2–3] | 3 [2–3] | 0.34 |
Per-patient median feed, g/h | 3.2 [1.9–4.8] | 3.3 [1.9–4.5] | 3.1 [2.0–5.3] | 0.58 |
Cohort 2 | Survivors | Non-survivors |
p Value | |
---|---|---|---|---|
Number of subjects | 80 | 63 | 17 | |
Age, years | 66 [54–75] | 65 [49–74] | 73 [57–76] | 0.50 |
Sex, M/F | 51/29 | 41/22 | 10/7 | 0.78 |
APACHE II score | 21 [17–27] | 21 [16–27] | 21 [17–28] | 0.60 |
First-day SOFA score | 7 [4–8] | 6 [4–8] | 8 [6–8] | 0.11 |
Cardiac | 3 [1–4] | 3 [1–4] | 4 [2–4] | |
Pulmonary | 3 [2–4] | 3 [2–4] | 4 [2–4] | |
Hepatic | 0 [0–0] | 0 [0–0] | 0 [0–1] | |
Renal | 0 [0–0] | 0 [0–0] | 0 [0–0] | |
Coagulation | 0 [0–1] | 0 [0–1] | 0 [0–1] | |
ICU length of stay, h | 180 [136–371] | 214 [142–405] | 142 [108–159] | <0.01 |
SPRINT duration, h | 155 [109–301] | 161 [126–332] | 110 [102–151] | 0.01 |
Diabetes mellitus type 1/type 2, % of total | 5/10 (15) | 4/8 (12) | 1/2 (3) | 1.00 |
Cohort BG, mmol/L | 5.7 [5.0–6.7] | 5.8 [5.1–6.8] | 5.6 [4.9–6.5] | <0.01a
|
Per-patient BG, mmol/L | 5.8 [5.3–6.2] | 5.9 [5.4–6.2] | 5.4 [5.2–6.0] | 0.11 |
Per-patient % BG, 4.4–8 mmol/L, % of all BG | 84.7 [73.6–91.7] (81.3) | 84.7 [74.0–91.7] (81.5) | 83.3 [71.5–94.8] (80.7) | 0.98 |
Per-patient % BG <4 mmol/L, % of all BG | 1.4 [0.0–2.8] (2.5) | 1.4 [0.0–2.8] (2.0) | 1.4 [0.0–5.6] (4.2) | 0.31 |
Number of patients with BG <2.2 mmol/L | 0 | 0 | 0 | |
BG measurements per day | 15.1 [13.8–16.3] | 15.1 [13.4–16.7] | 15.4 [14.7–15.9] | 0.66 |
Per-patient median insulin, U/h | 3 [2–3] | 3 [3–3] | 3 [2–3] | 0.40 |
Per-patient median feed, g/h | 3.3 [1.9–4.8] | 3.5 [1.9–4.6] | 2.8 [2.1–5.6] | 0.80 |
Model-based SI
Parameter | Description |
---|---|
G(t) | Blood glucose level (mmol/L) |
I(t) | Plasma insulin concentration (mU/L) |
Q(t) | Interstitial insulin concentration (mU/L) |
P(t) | Glucose appearance in plasma from dextrose intake (mmol/minute) |
S
I
| Insulin sensitivity (L/mU/minute) |
Analyses and statistics
Results
SI level
Hours
|
Cohort 1: (n = 145 patients) | |||
Survivors (SI
S
) L/mU/minute × 10−4
| Non-survivors (SI
NS
) L/mU/minute × 10−4
| Median SI
S
− SI
NS
[95% CI] L/mU/minute × 10−4
| ||
Day 1 | ||||
0–5 | 1.39 [0.50, 2.54] | 1.64 [0.63, 2.63] | −0.25 [−0.60, 0.06] |
×
|
6–11 | 1.94 [1.11, 3.35] | 2.58 [1.42, 3.97] |
−0.63 [−1.04, −0.11]
a,b
|
×
|
12–17 | 2.54 [1.42, 4.48] | 3.39 [1.63, 4.79] | −0.79 [−1.46, 0.22] |
×
|
18–23 | 2.76 [1.57, 5.09] | 3.22 [1.93, 5.16] | −0.42 [−0.93, 0.14] |
×
|
Day 2 | ||||
24–29 | 2.96 [1.65, 4.98] | 3.30 [1.81, 4.85] | −0.30 [−0.73, 0.13] |
×
|
30–35 | 3.08 [1.83, 5.73] | 4.34 [2.35, 7.21] |
−1.23 [−2.16, −0.20]
a
|
×
|
36–41 | 3.13 [1.81, 5.44] | 3.42 [2.23, 5.36] | −0.29 [−1.01, 0.43] |
×
|
42–47 | 3.22 [1.81, 5.47] | 4.43 [2.48, 6.24] | −0.25 [−0.94, 0.16] |
×
|
Day 3 | ||||
48–53 | 3.28 [1.95, 5.36] | 4.83 [3.13, 8.63] |
−1.57 [−2.36, −0.97]
a,b
|
×
|
54–59 | 3.55 [2.03, 5.50] | 4.65 [2.53, 7.27] |
−1.12 [−2.04, −0.40]
a
|
×
|
60–65 | 3.39 [2.18, 5.18] | 4.19 [2.71, 6.83] |
−0.81 [−1.59, −0.01]
a
|
×
|
66–71 | 3.40 [2.43, 5.07] | 3.86 [2.43, 8.30] | −0.47 [−1.43, 0.16] |
×
|
Hours
|
Cohort 2: (n = 80 patients) | |||
Survivors (SI
S
) L/mU/minute × 10−4
| Non − Survivors (SI
NS
) L/mU/minute × 10−4
| Median SI
S
− SI
NS
[95% CI] L/mU/minute × 10−4
| ||
Day 1 | ||||
0–5 | 1.39 [0.43, 2.45] | 1.38 [0.30, 2.54] | −0.00 [−0.52, 0.57] |
×
|
6–11 | 1.90 [0.92, 3.66] | 2.22 [1.15, 3.62] | −0.33 [−1.00, 0.02] |
×
|
12–17 | 2.36 [1.37, 4.48] | 2.46 [1.46, 4.50] | −0.12 [−1.19, 0.61] |
×
|
18–23 | 2.63 [1.53, 4.47] | 2.94 [1.87, 4.50] | −0.30 [−0.81, 0.14] |
×
|
Day 2 | ||||
24–29 | 2.95 [1.53, 4.52] | 3.19 [1.65, 4.82] | −0.26 [−0.75, 0.22] |
×
|
30–35 | 3.04 [1.88, 5.07] | 3.56 [2.24, 6.85] | −0.55 [−1.95, 0.12] |
×
|
36–41 | 3.06 [1.79, 4.94] | 3.15 [2.14, 5.04] | −0.10 [−0.79, 0.51] |
×
|
42–47 | 3.21 [1.80, 5.23] | 3.41 [2.93, 5.27] | −0.24 [−0.86, 0.22] |
×
|
Day 3 | ||||
48–53 | 3.31 [1.98, 5.30] | 4.59 [3.03, 8.20] |
−1.26 [−1.84, −0.41]
a,b
|
×
|
54–59 | 3.59 [2.09, 5.50] | 4.37 [2.43, 7.36] |
−0.87 [−1.81, −0.09]
a
|
×
|
60–65 | 3.45 [2.18, 5.24] | 3.94 [2.62, 6.53] | −0.48 [−1.37, 0.25] |
×
|
66–71 | 3.41 [2.43, 5.21] | 3.68 [2.42, 7.56] | −0.30 [−1.20, 0.24] |
×
|
SI variability (%ΔSI)
Hours
|
Cohort 1: (n = 145 patients) | ||||
Survivors (%∆SI
S
) % | Non-survivors (%∆SI
NS
) % | Kolmogorov-Smirnov test p value | Median %∆SI
S
-%∆SI
NS
[95% CI] % | ||
Day 1 | |||||
0–5 | 1.46 [−29.26, 54.74] | 11.67 [−20.84, 56.41] | 0.67 | −8.12 [−16.22, 4.67] | ⇔ |
6–11 | 7.37 [−14.66, 42.05] | 9.47 [−11.45, 27.98] | 0.53 | −1.31 [−6.22, 5.74] | ⇔ |
12–17 | 5.21 [−11.87, 30.89] | 6.69 [−14.89, 42.15] | 0.62 | −0.98 [−9.46, 7.26] | ⇔ |
18–23 | 3.24 [−16.02, 26.92] | −0.63 [−12.21, 16.37] | 0.12 | 3.72 [−1.99, 8.56] | ⇔ |
Day 2 | |||||
24–29 | 2.79 [−13.36, 23.35] | 5.37 [−9.42, 23.52] | 0.30 | −2.70 [−8.60, 3.29] | ⇔ |
30–35 | 1.76 [−15.13, 23.46] | 1.57 [−11.32, 24.75] | 0.78 | 0.34 [−8.54, 6.75] | ⇔ |
36–41 | 1.92 [−12.19, 16.87] | −4.01 [−15.63, 11.26] |
0.04
|
6.10 [0.35, 10.70]
a
| ⇔ |
42–47 | −0.10 [−12.71, 17.98] | 5.46 [−10.91, 21.91] | 0.14 |
−5.66 [−11.61, −0.43]
a
| ⇔ |
Day 3 | |||||
48–53 | 1.57 [−10.74, 16.82] | 3.41 [−7.30, 14.99] | 0.30 | −2.12 [−7.41, 1.77] | ⇔ |
54–59 | 0.67 [−11.68, 15.80] | −3.13 [−19.08, 11.65] | 0.35 | 3.37 [−1.77, 8.20] | ⇔ |
60–65 | 2.39 [−12.39, 17.03] | 4.89 [−8.88, 21.88] | 0.45 | −2.50 [−9.06, 3.35] | ⇔ |
66–71 | 1.26 [−9.80, 12.87] | 3.78 [−8.82, 15.48] | 0.35 | −2.76 [−8.66, 2.80] | ⇔ |
Hours
|
Cohort 2: (n = 80 patients) | ||||
Survivors (%∆SI
S
) % | Non-survivors (%∆SI
NS
) % | Kolmogorov-Smirnov test p value | Median %∆SI
S
-%∆SI
NS
[95% CI] % | ||
Day 1 | |||||
0–5 | 0 [−29.44, 43.57] | 0.98 [−20.90, 57.81] | 0.78 | −0.98 [−16.02, 5.93] | ⇔ |
6–11 | 8.80 [−14.66, 48.55] | 10.59 [−17.24, 39.20] | 0.90 | −2.17 [−11.46, 6.83] | ⇔ |
12–17 | 2.38 [−13.18, 29.19] | 2.92 [−15.99, 38.92] | 0.89 | −0.02 [−11.00, 9.19] | ⇔ |
18–23 | 4.09 [−14.80, 26.14] | −2.13 [−11.66, 15.29] | 0.11 |
6.16 [0.10, 12.10]
a
| ⇔ |
Day 2 | |||||
24–29 | 1.32 [−13.48, 20.79] | 10.39 [−8.97, 25.86] |
0.02
|
−9.23 [−14.18, −1.38]
a
| ⇔ |
30–35 | 0.13 [−15.56, 21.72] | 3.08 [−13.33, 23.03] | 0.89 | −2.38 [−10.72, 4.79] | ⇔ |
36–41 | 2.54 [−12.13, 18.20] | 0.40 [−11.95, 15.13] | 0.39 | 2.95 [−1.86, 9.51] | ⇔ |
42–47 | 1.37 [−13.37, 22.76] | 2.42 [−11.83, 14.68] | 0.46 | −1.02 [−7.15, 5.68] | ⇔ |
Day 3 | |||||
48–53 | 0.88 [−10.32, 16.63] | 3.16 [−7.25, 14.62] | 0.30 | −2.37 [−7.73, 1.79] | ⇔ |
54–59 | 0.72 [−10.36, 14.28] | −1.17 [−19.08, 12.68] | 0.32 | 2.69 [−3.18, 7.71] | ⇔ |
60–65 | 2.58 [−10.54, 16.38] | 4.04 [−9.03, 21.96] | 0.39 | −1.89 [−8.44, 3.76] | ⇔ |
66–71 | 1.26 [−9.74, 11.54] | 3.72 [−9.06, 14.81] | 0.40 | −2.62 [−8.81, 3.12] | ⇔ |
Key results
-
SI level is not equivalent in any 6-h block within the first 72 h of GC, and it is sometimes statistically different between survivors and non-survivors.
-
SI level is higher in non-survivors than in survivors in every 6-h block for the first 72 h, and this difference becomes statistically significant as GC progresses.
-
SI variability is equivalent between survivors and non-survivors in any 6-h block within the first 72 h of GC.
-
Patient dropout had no impact on results, because Cohort 2 had the same key outcomes.
-
The major results are consistent, regardless of whether the Bonferroni correction for multiple comparisons is applied.